11.02
前日終値:
$11.44
開ける:
$11.3
24時間の取引高:
450.06K
Relative Volume:
0.91
時価総額:
$453.61M
収益:
$324.01M
当期純損益:
$-192.37M
株価収益率:
-2.3054
EPS:
-4.78
ネットキャッシュフロー:
$-23.46M
1週間 パフォーマンス:
-14.25%
1か月 パフォーマンス:
-18.26%
6か月 パフォーマンス:
+19.80%
1年 パフォーマンス:
+17.13%
Angiodynamic Inc Stock (ANGO) Company Profile
ANGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ANGO
Angiodynamic Inc
|
11.01 | 471.33M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
597.76 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.34 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.89 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
248.58 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.34 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-16 | 開始されました | Lake Street | Buy |
| 2024-04-05 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 開始されました | H.C. Wainwright | Buy |
| 2023-04-17 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 開始されました | Oppenheimer | Perform |
| 2020-11-25 | アップグレード | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | ダウングレード | Craig Hallum | Buy → Hold |
| 2017-04-07 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-03-30 | ダウングレード | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 開始されました | Barclays | Equal Weight |
| 2016-11-04 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-04-08 | 再開されました | Piper Jaffray | Neutral |
| 2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 繰り返されました | Canaccord Genuity | Hold |
| 2012-06-25 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | アップグレード | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | ダウングレード | Wedbush | Neutral → Underperform |
| 2010-09-08 | 繰り返されました | Wedbush | Neutral |
すべてを表示
Angiodynamic Inc (ANGO) 最新ニュース
ANGIODYNAMICS INC SEC 10-Q Report - TradingView — Track All Markets
AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Why AngioDynamics Stock Is Sinking Today - The Motley Fool
Why hedge funds are buying AngioDynamics Inc. stock2026 world cup usa national team third place match young talents pressing system match prediction breakdown - Улправда
AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Aug Decliners: Will AngioDynamics Inc stock benefit from AI adoptionBear Alert & Accurate Entry/Exit Alerts - moha.gov.vn
AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha
Trend Recap: Why AngioDynamics Inc UG2 stock remains top ratedTrade Exit Summary & Low Risk High Reward Trade Ideas - moha.gov.vn
AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? - Yahoo Finance
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz
Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan
New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan
Why AngioDynamics Inc. stock remains on buy listsWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
Will AngioDynamics Inc. stock attract more institutional investorsSwing Trade & Growth Focused Stock Pick Reports - Улправда
How rising interest rates impact AngioDynamics Inc. stockTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
How the Printed Matter Doctrine Sees Through X-Ray Markers - Patently-O
AngioDynamics (NASDAQ:ANGO) Reaches New 1-Year HighWhat's Next? - MarketBeat
Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st
AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - Defense World
AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance
Dynamic Technology Lab Private Ltd Purchases Shares of 29,317 AngioDynamics, Inc. $ANGO - MarketBeat
Buyback Watch: How rising interest rates impact AngioDynamics Inc. stockTrade Risk Summary & Weekly Top Performers Watchlists - BỘ NỘI VỤ
AXQ Capital LP Has $270,000 Holdings in AngioDynamics, Inc. $ANGO - Defense World
Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO - Defense World
Will AngioDynamics Inc. (UG2) stock maintain strong growthJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
[8-K] ANGIODYNAMICS INC Reports Material Event | ANGO SEC FilingForm 8-K - Stock Titan
How strong is AngioDynamics Inc. stock balance sheetTake Profit & Low Risk High Reward Ideas - Fundação Cultural do Pará
Why AngioDynamics Inc. stock is in analyst buy zoneJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How AngioDynamics Inc. stock reacts to job market dataTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Fundação Cultural do Pará
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - Fundação Cultural do Pará
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Insider Monkey
Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Angiodynamic Inc (ANGO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):